Moderna (MRNA) rose 13.1% on 4 Nov 2026. The stock closed at $258.38, against $228.44 the session before.
That puts the company's market value at about $103.2B. The 52-week range is $22.28 to $258.72, so the stock now sits 0.1% below the top of it.
Over the past 52 weeks the shares have moved +869.6%.
Figures from Yahoo Finance at the time of writing. Not investment advice.